A High-Quality Developer, Manufacturer, and Distributor of Pharmaceuticals

Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer

According to the NMPA official website, the drug approval certificates delivery information released on February 19, 2024, 51 varieties(81 Specifications)BRILLIANT PHARMACEUTICALS, Qilu Pharmaceutical, and Humanwell Healthcare Group Co. Ltd.
Among them,Furosemide Oral Solution, Magnesium Aluminum Carbonate Suspension, Dacarbazine for InjectionThree varieties have received their first approval.
In addition, Shanghai Huayuan Anhui Jinhui Pharmaceutical 2 varietiesApproved on the same day,Acetylcysteine Effervescent TabletsApproved on the same day by Jiangsu Anbisen Pharmaceutical and Ningbo Meinuohua Tiankang Pharmaceutical, two companies.Cefoperazone Sodium and Sulbactam Sodium for InjectionAcquired Shandong Runze Pharmaceutical and Fuan Pharmaceutical GroupTwo companies approved on the same day.
Table 1: Varieties Passed Evaluation on 02.19 (First to Pass Marked in Red)

END
Reply to the keyword "Report", access dozens of exclusive reports produced by Yaorongyun
Reply to the keyword "CSCO", Obtain 2023 CSCO Guidelines
Reply to the keyword "ASCO", Obtain 2023 ASCO Abstract by Cancer Type
Reply to the keyword "First Generic in 2022", Obtain the List of First Generic Drugs Approved in 2022
Reply to the keyword "Medical Insurance", Obtain the 2022 Medical Insurance Catalog
Contact us to experience more professional services from PharmaRain | ||||
WillDiscussion CombinedWork | GardenDistrict TakeWu | Database Consultation | Customization Service | Media Cooperation |



